glp 1 agonist cardiovascular outcomes outcome studies with GLP-1 receptor Results of cardiovascular outcomes trials

This article reviews the efficacy and safety of different strategies to initiate and intensify basal insulin, with focus on new fixed ratio combinations of basal insulin with GLP-1 RAs available for use in a single injection pen (insulin degludec/liraglutide and insulin glargine/lixisenatide).

Mounjaro is dual-acting, while Ozempic affects one gut hormone.

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

This blog covers the impact of high-fiber foods, protein-rich meals, probiotics, allulose, and intermittent fasting on GLP-1

Metabolic Benefits: Along with weight loss, it has shown promising results in treating Type 2 diabetes, with some studies showing hemoglobin A1c reductions